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changes in their parent neuron activities and reciprocal presynap-
tic regulation of release (Calabresi et al., 2000; Zhou et al., 2002; 
Centonze et al., 2003; Pisani et al., 2003; Morris et al., 2004; Cragg, 
2006). In addition, it is essential to consider that the striatum is 
a heterogeneous nucleus, and is organized into different (albeit 
overlapping) territories, anatomically, biochemically, functionally, 
and also neurochemically in terms of neurotransmitter interactions 
(Haber et al., 2000; Nakano et al., 2000; Cragg, 2003; Voorn et al., 
2004; Belin et al., 2009).
A primary focus of our work is to understand how ACh regulates 
striatal DA neurotransmission across different striatal regions and 
under conditions representing the physiological repertoire of activ-
ity patterns of DA neurons. We use the real time electrochemical 
detection technique, fast-scan cyclic voltammetry at carbon fiber-
microelectrodes to be able to explore subsecond DA transmission. 
This work will help us to understand how striatal DA availability 
varies with DA neuron activity. In this Perspective, we will draw from 
recent findings to summarize our current understanding of how 
ACh modulates DA transmission via actions at both nicotinic and 
muscarinic receptors. This regulation occurs in a variable manner 
dependent on DA neuron activity, and moreover, involves differ-
ent receptor subtypes/subunits in sensorimotor- versus limbic-
associated striatum.
Dopamine anD acetylcholine systems in the 
striatum
striatal subterritories
Collectively, the striatum participates in a wide variety of moti-
vational, associative, and sensorimotor-related brain functions 
(Albin et al., 1995; Haber et al., 2000; Gerdeman et al., 2003; 
introDuction
The striatum is a large subcortical nucleus involved in motor co-
ordination and cognition, as well as disorders such as Parkinson’s 
disease, Tourette’s syndrome, Huntington’s disease, schizophrenia, 
and drug addiction (Wilson, 2004). The principal neurons of the 
striatum are the medium spiny neurons (MSNs) which constitute 
∼90% of the striatal neuron population and form the striatal output 
(Bolam et al., 2000). The remaining striatal neurons are comprised of 
at least three types of interneuron, including the large, aspiny, toni-
cally active cholinergic interneuron (Kawaguchi, 1993). As the input 
nucleus of the basal ganglia, the striatum receives, and gates massive 
convergent innervation via the MSNs to generate appropriate behav-
iors. Among this convergent innervation, striatal projection neurons 
receive dopaminergic inputs from the midbrain alongside excitatory 
inputs from both cortex and thalamus. Nigrostriatal dopaminergic 
afferents and corticostriatal/thalamostriatal glutamatergic afferents 
commonly synapse onto the same MSN dendritic spine (Moss and 
Bolam, 2008). Dopamine (DA) is therefore well positioned within 
this synaptic triad to shape striatal output.
In order to appreciate the significance of discrete activity in 
DA neurons to striatal function it is important to consider fac-
tors controlling the availability of DA from axon terminals in the 
striatum. Acetylcholine (ACh) and DA have dense overlapping 
axonal arborizations and a potent reciprocal relationship within 
the striatum. Mesostriatal DA neurons and striatal cholinergic 
interneurons participate in signaling the motivational significance 
of environmental stimuli and regulate striatal plasticity (Schultz, 
1998, 2002; Calabresi et al., 2000; Partridge et al., 2002; Morris et al., 
2004). Interactions between these neurotransmitters in the striatum 
occur at presynaptic and postsynaptic levels, through  synchronous 
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Voorn et al., 2004; Everitt and Robbins, 2005; Schultz, 2006). The 
striatum is a highly heterogeneous structure where the principal 
neurons, the MSNs, are intermingled in an irregular fashion with 
at least three different types of interneuron as well as a variety of 
inputs from cortex, thalamus, and midbrain. Within this hetero-
geneous structure, subterritories exist which differ according to 
their functional roles as well as their afferent inputs from, and 
projections to other nuclei. For example, dorsal striatal regions are 
classically associated with sensorimotor function, with glutamater-
gic afferents from motor cortex and dopaminergic afferents from 
substantia nigra pars compacta (SNc; McGeorge and Faull, 1989; 
Haber et al., 2000; Reep et al., 2003). Ventral striatal regions are 
associated with limbic function with glutamatergic afferents from 
prefrontal cortex, amygdala and hippocampus, and dopaminergic 
afferents from ventral tegmental area (VTA; Kelley and Domesick, 
1982; McGeorge and Faull, 1989; Sesack et al., 1989; Brog et al., 
1993; Pennartz et al., 1994; O’Donnell and Grace, 1995; Haber et al., 
2000). When exploring factors which regulate striatal DA availabil-
ity, it is therefore important to consider different striatal subterri-
tories, especially when considering potential therapeutic targets for 
which a regional specificity of action may be ideal. And yet, while 
these regions are delineated in many respects, they also interact 
through interconnections and other crosstalk (Haber et al., 2000; 
Belin and Everitt, 2008; Belin et al., 2009). Therefore, factors which 
have distinct regulatory functions within one striatal region may 
also have important consequences for function in other regions.
Dopamine anD acetylcholine Distribution in striatum
A high density of dopaminergic and cholinergic terminals exists in 
the striatum and they are often only about 1 μm apart (Descarries 
et al., 1997). DA inputs to the striatum arise predominantly from 
the “A9”–“A10” DA neurons in the midbrain. Neurons in the VTA 
and SNc project in a topographic pattern to differentially innervate 
the ventral striatum (nucleus accumbens, NAc) and the dorsal 
striatum (caudate–putamen, CPu) respectively (Bjorklund and 
Lindvall, 1984; Gerfen et al., 1987; McFarland and Haber, 2000; 
Voorn et al., 2004). Mesostriatal DA neurons exhibit two broad 
and well-defined firing modes in vivo; single-spike firing in regular 
or irregular patterns (∼1–10 Hz) and burst firing of 3–5 spikes at 
a frequency of ∼15–100 Hz (Grace and Bunney, 1984a,b; Hyland 
et al., 2002), and there are also periods when DA neurons are in 
a hyperpolarized, quiescent state. The switch in firing mode of 
mesostriatal DA neurons, from low to higher firing frequencies, is 
thought to encode information about the prediction and receipt 
of reward or behaviorally salient stimuli (Schultz, 1986, 2002; 
Morris et al., 2004; Matsumoto and Hikosaka, 2009). Despite DA 
neurons forming a relatively small population of neurons, a single 
DA neuron projecting to the striatum forms a very dense arbor, 
occupying up to 5.7% of the volume of the striatum, with a high 
density of axonal varicosities forming a synapse approximately 
every 10–20 μm3 (Descarries et al., 1996; Arbuthnott and Wickens, 
2007; Matsuda et al., 2009; Moss and Bolam, 2010). Furthermore, 
an individual DA neuron is thought to make several hundred thou-
sand synapses – at least an order of magnitude higher than most 
other CNS neurons (Matsuda et al., 2009). Although DA neurons 
make a huge number of structurally defined synapses, DA recep-
tors and uptake transporters exist extrasynaptically (Nirenberg 
et al., 1996, 1997; Pickel, 2000) and DA is able to spillover from the 
synapse to participate in extrasynaptic or “volume” transmission 
(Fuxe and Agnati, 1991; Garris et al., 1994; Gonon, 1997; Cragg 
and Rice, 2004; Rice and Cragg, 2008). DA is therefore extremely 
well positioned to modulate striatal function: DA synapses are 
situated on the necks of spines of MSNs adjacent to corticostriatal 
or thalamostriatal glutamatergic inputs (Freund et al., 1984; Smith 
and Bolam, 1990; Groves et al., 1994; Moss and Bolam, 2008). DA 
receptors are present throughout the striatum, with D1-like recep-
tors on striatonigral MSNs (Hersch et al., 1995; Matamales et al., 
2009) and D2-like receptors on striatopallidal MSNs, cholinergic 
interneurons as well as DA axons (Sesack et al., 1994; Alcantara 
et al., 2003; Matamales et al., 2009).
In the striatum, cholinergic innervation arises solely from cholin-
ergic interneurons (Woolf, 1991; Contant et al., 1996; Calabresi 
et al., 2000), which despite representing only 1–2% of all striatal 
neurons, provide an extensive axonal arborization throughout the 
striatum in a manner similar to dopaminergic axons. Quantitative 
electron microscopy studies indicate approximately 2 × 108 ACh 
varicosities/mm3 in the striatum, and each striatal cholinergic 
interneuron has 500,000 axon varicosities. Similar to dopamin-
ergic axon terminals, a 10-μm-radius sphere of striatal neuropil 
contains about 400 cholinergic axon terminals (Contant et al., 1996; 
Descarries and Mechawar, 2000). These cholinergic interneurons 
are spontaneously active in the striatum (Bennett and Wilson, 1999; 
Zhou et al., 2001, 2003). Similar to dopaminergic neurons, cholin-
ergic interneurons are also critically involved in signaling learning 
associated with events of unexpected high salience (Calabresi et al., 
2000; Schultz, 2002; Berridge and Robinson, 2003; Centonze et al., 
2003; Wickens et al., 2003; Wise, 2004). Whilst DA neurons signal 
these events by switching from low to higher frequency, burst firing 
modes (Schultz, 1986, 2002; Morris et al., 2004; Matsumoto and 
Hikosaka, 2009), cholinergic interneurons respond simultaneously 
with a pause in firing which can also be flanked by a preceding 
and succeeding brief high frequency firing in a “burst-pause-burst” 
pattern (Morris et al., 2004; Joshua et al., 2008). The coincident 
timing of activity changes in DA and ACh neurons associated with 
events of unexpected salience highlights the synchronous interac-
tion between these transmitters in the striatum.
Both DA and ACh are able to participate in extrasynaptic signal-
ing (i.e., volume transmission; Descarries et al., 1996, 1997; Zoli 
et al., 1998), but the close proximity of striatal dopaminergic and 
cholinergic terminals ensures interactions between the dopamin-
ergic and cholinergic systems. Indeed, the co-operative interactions 
of the dopaminergic and cholinergic systems are very important 
for the proper functioning of the striatum (Calabresi et al., 2000; 
Centonze et al., 2003; Rice and Cragg, 2004; Zhang and Sulzer, 
2004; Cragg et al., 2005). There is a longstanding hypothesis of 
an antagonistic balance between DA and ACh in normal striatal 
function (Calabresi et al., 2000; Zhou et al., 2002; Centonze et al., 
2003; Pisani et al., 2003). This hypothesis arose from studies which 
found that both DA replacement treatments and anti-cholinergic 
treatments were able to alleviate the debilitating motor symptoms 
of Parkinson’s disease (Barbeau, 1962; Pisani et al., 2003), and 
at the postsynaptic level, DA and ACh can have opposing effects 
on the excitability of striatal output neurons and on corticostri-
atal plasticity (Calabresi et al., 2000, 2007; Centonze et al., 2003; 
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Ligands for nAChRs have long been known to have a powerful 
control over striatal DA release (Di Chiara and Imperato, 1988; 
Dajas-Bailador and Wonnacott, 2004). However, we now appreciate 
that the control of DA release probability by ACh and presynaptic 
nAChRs is dynamic and complex depending on the activity of DA 
neurons and multiple nAChR subunits (Zhou et al., 2001; Rice and 
Cragg, 2004; Zhang and Sulzer, 2004; Exley et al., 2008; Drenan 
et al., 2010; Threlfell et al., 2010). Typically, striatal DA release is 
associated with a use-dependent, short-term depression of release 
probability at short inter-pulse intervals (Abeliovich et al., 2000; 
Cragg, 2003; Montague et al., 2004). Studies using real time elec-
trochemical detection of DA in striatal slices indicate that ACh 
released from tonically active cholinergic interneurons (Bennett and 
Wilson, 1999; Zhou et al., 2001, 2003) acts at β2-subunit-containing 
 (β2*)-nAChRs on striatal DA axons contributing to the high prob-
ability of DA release evoked by a single pulse (Zhou et al., 2001; Rice 
and Cragg, 2004). Reducing ACh actions at nAChRs by applica-
tion of nAChR antagonists, or by desensitization of nAChRs using 
nicotine, reduces initial DA release probability and subsequently 
relieves short-term depression (Figure 1; Rice and Cragg, 2004; 
Zhang and Sulzer, 2004). ACh therefore contributes to the initial 
probability that DA is released, and in turn, the subsequent short-
term depression of DA release.
One of the key consequences of ACh activation of nAChRs on 
dopaminergic axons is a limit placed on how subsequent action 
potentials in a train, or burst, can evoke further DA release. In other 
words, ACh action at nAChRs promotes how DA axons release in 
response to single or low frequency action potentials, but at the 
Pisani et al., 2003; Morris et al., 2004). Their interactions in situ 
may however be co-operative (Morris et al., 2004; Cragg, 2006), 
since the direction of physiological changes in activities of DA and 
ACh neurons during behavior is opposite.
Striatal ACh acts at two classes of cholinergic receptors, nico-
tinic acetylcholine receptors (nAChRs), and muscarinic acetyl-
choline receptors (mAChRs). Nicotinic receptors are ligand-gated 
ion channels composed of five subunits arranged symmetrically 
around a central pore. Muscarinic receptors are seven transmem-
brane domain, G-protein-coupled receptors. ACh via actions at 
both mAChRs and nAChRs is able to powerfully regulate striatal 
DA availability in a manner which differs according to the striatal 
subregion and DA neuron activity. In addition, the subtypes of 
both mAChRs and nAChRs responsible differ between dorsal and 
ventral striatal territories.
Frequency-DepenDent regulation oF Dopamine 
release probability by presynaptic nicotinic 
receptors (nachrs)
Striatal DA release may not correlate directly with the activity of 
DA neurons in midbrain due to mechanisms that may include 
use-dependent changes or “plasticity” in DA release probability 
(Chergui et al., 1994; Cragg, 2003; Montague et al., 2004) as seen 
at other CNS synapses. Within the striatum, DA release probability 
following a single action potential is relatively high, with subsequent 
short-term depression limiting further release by subsequent action 
potentials within a burst of action potentials (Schmitz et al., 2002; 
Cragg, 2003).
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Figure 1 | Nicotinic (nAChrs) and muscarinic (mAChrs) receptors modify 
frequency-dependence of dopamine release. (A,B) Profiles of mean 
extracellular concentration of dopamine [DA]o ± SEM versus time in NAc after 
stimuli (arrows) of either a single pulse (1p) or a high frequency burst (4p/100 Hz) 
in control or drug conditions (DHβE, 1 μM; Oxo-M, 10 μM). Data are normalized 
to peak [DA]o released by 1p in controls. Either β2*-nAChR antagonist (DHβE) or 
mAChR agonist (Oxo-M) reduce release by a single pulse and enhance release 
by a burst thereby increasing the contrast between dopamine released by burst 
and non-burst activity. (C,D) Mean peak [DA]o ± SEM versus frequency during 
four pulse trains (1–100 Hz) in control (filled circles) or DHβE (squares) or Oxo-M 
(triangles) normalized to [DA]o released by a single pulse in control conditions. 
Either blockade of nAChRs with DHβE, or activation of mAChRs with Oxo-M 
results in increased frequency-dependence of dopamine release as described 
previously (see Rice and Cragg, 2004; Exley et al., 2008; Threlfell et al., 2010). (e) 
Schematic illustrating the frequency-dependence of dopamine release during 
deactivation of nAChRs as a result of either blockade/desensitization of 
presynaptic nAChRs on dopamine terminals or activation of mAChRs on 
cholinergic interneurons.
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at high density in DA axon terminals in rodent striatum, where 
they can assemble as functional heteromeric nicotinic receptors. 
As heteromeric receptors, nicotinic subunits arrange to form two 
α/β pairs, and a fifth subunit, α or β. The boundary of each α/β 
pair is one of two ACh-binding sites at each nAChR (Gotti and 
Clementi, 2004) which must be occupied for the receptor to func-
tion. In striatal DA axons, the two α/β pairs are the α4/β2 and/
or α6/β2 and/or α4/β4 (Luetje, 2004; Salminen et al., 2004; Quik 
et al., 2005). The fifth subunit in the nAChR pentamer may consist 
of any other subunit, including α5 or β3.
All nAChRs on striatal DA axon terminals are thought to con-
tain the β2 subunit (Champtiaux et al., 2003; Salminen et al., 
2004). Deduction of the other subunits present within these β2*-
nAChRs has been aided by use of a selective α6-/α3*-nAChR 
antagonist α-conotoxin MII (α-CtxMII; Cartier et al., 1996; 
Whiteaker et al., 2000; McIntosh et al., 2004). The majority of 
striatal nAChRs located on DA terminals can therefore be sepa-
rated into two groups according to their sensitivity to α-CtxMII. 
Studies using α-CtxMII to determine which nAChR subunits are 
responsible for nicotine-evoked striatal DA release from synap-
tosomes have revealed that up to 60% of nicotine-evoked DA is 
not prevented by α-CtxMII and therefore results from non-α6*-
nAChRs (Kulak et al., 1997; Kaiser et al., 1998; Salminen et al., 
2007). Therefore both α6*-nAChRs (comprising α6α4β2β3 and 
α6/β2*) and non-α6*-nAChRs (comprising α4β2 and α4α5β2) 
exist on striatal DA axons (Zoli et al., 2002; Champtiaux et al., 
2003; Salminen et al., 2004; Quik et al., 2005; Exley and Cragg, 
2008; Gotti et al., 2009; Jennings et al., 2009). However as emerg-
ing data is beginning to indicate, expression does not necessarily 
indicate function.
nachr subunits responsible For regulation oF striatal 
Dopamine transmission in Dorsal versus ventral striatum
Previous studies identifying the subunits responsible for nicotinic 
regulation of striatal DA release from synaptosomes have typically 
not differentiated between striatal subterritories. It is important 
to distinguish factors (such as nAChR subunits) regulating DA 
availability across different striatal subregions due to different the 
behaviors associated with distinct striatal subterritories. For exam-
ple, DA neurons innervating more dorsal striatal regions are those 
most vulnerable in Parkinson’s disease, therefore understanding 
mechanisms regulating availability of DA within such territories 
will help to unveil future therapeutic targets/neuroprotective strate-
gies in such diseases.
Recent work from our own lab using the α6-selective nAChR 
antagonist α-CtxMII has revealed that α6*-nAChRs dominate 
activity-dependent regulation of DA transmission in ventral stria-
tum, whereas in dorsal striatum α6*-nAChRs play a minor role 
(Exley and Cragg, 2008; Exley et al., 2008). Due to a lack of other 
subunit-specific pharmacological nAChR ligands, further deline-
ation of the nAChR subunits necessary for activity-dependent 
regulation of DA transmission requires the use of subunit-null 
and transgenic mice expressing mutant nAChR subunits. A recent 
study using mice expressing a non-native hypersensitive α6 subunit 
(α6′) revealed activity-dependent DA release in central CPu in the 
absence of any nAChR ligand. This activity-dependence was absent 
in α6′ mice lacking α4 subunits (α6′α4KO), which the authors 
expense of greater release during high frequency action potentials, 
e.g., in a burst. Thus, nAChRs limit how well striatal DA release cor-
relates with the frequency of activity of DA neurons in midbrain; 
nAChR activity promotes a “low frequency pass” filter. Conversely, 
when nAChRs are turned off, and short-term depression of DA 
release probability is relieved, striatal DA release becomes highly 
sensitive to the frequency of activity of DA neurons. It can be viewed 
that nAChR blockade suppresses initial DA release but permits a 
“high frequency pass” filter as seen at many CNS synapses (Rice and 
Cragg, 2004; Cragg, 2006). Consequently, reduced nAChR activity 
can (a) augment DA release following bursts of DA neuron activity 
(>20 Hz) such as those that accompany presentation of unexpected 
reward or conditioned salient stimuli (Mirenowicz and Schultz, 
1996; Hyland et al., 2002) and (b) reduce DA release during low DA 
neuron activity such as that seen following omission of a expected 
reward (Tobler et al., 2003). This enhanced sensitivity of DA release 
to activity in DA neurons during low nAChR activity may occur 
during pauses in activity in ACh interneurons.
This ability of ACh via nAChRs to regulate DA availability in a 
manner that is dependent on frequency of DA neurons suggests that 
changes in ACh interneuron activity, e.g., pauses, will have key con-
sequences on DA signaling when DA neurons concurrently switch 
from firing at low frequencies to bursts of high frequency activity, 
such as during events of high salience. A pause in the nAChR filter-
ing mechanism will increase the contrast in DA signaling during 
different modes of activity of DA neurons and ultimately enhance 
DA function at the level of the MSN by modulating DA action at 
D1 or D2 receptors on discrete MSN populations as well as other 
DA receptor-expressing interneurons/axons.
nachr subunits on striatal Dopamine axons
Dopamine neurons express a range of nAChR subunits, and several 
different stoichiometric configurations are proposed to exist in DA 
axons and regulate striatal DA transmission. Currently, 14 mam-
malian nAChR subunits α1–α10 and β1–β4 have been identified. 
These subunits are organized into subfamilies I–IV, according to 
gene sequence and structure (Corringer et al., 2000; Le Novere et al., 
2002). To date, only nine nAChR subunits from subfamilies II (α7) 
and III (α2–α6, β2–β4) have been identified in mammalian brain 
(Corringer et al., 2000; Le Novere et al., 2002). These subunits can 
form homomeric pentamers (all of one type of subunit, e.g., α7) 
or heteromeric pentamers, consisting of combinations of various 
α- and β-type subunits. In rodents, DA neurons in VTA and SNc 
express mRNAs for the nAChR subunits α4, α5, α6, β2, and β3, 
as well as lower levels of α3, α7, and β4 (Azam et al., 2002). This 
diversity of subunit expression has the potential to give rise to mul-
tiple types of pentameric receptors in somatodendritic and axon 
terminal regions of DA neurons with a corresponding multitude 
of potential functions.
Differences in the nAChR subunits present in axon terminals 
versus somatodendritic regions of DA neurons exist. Whereas α7- 
and β4-subunits are present in VTA and SNc, they are not present 
in DA axon terminals in striatum (Champtiaux et al., 2003; Quik 
et al., 2005). Furthermore, despite existing in the primate striatum, 
there is no α3-subunit in rodent striatum (Wonnacott et al., 2000; 
Zoli et al., 2002; Champtiaux et al., 2003; Gotti et al., 2005; Quik 
et al., 2005). The α4, α5, α6, β2, and β3 subunits are however found 
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Alcantara et al., 2001; Zhang et al., 2002a), which are autoreceptors. 
When these autoreceptors are activated cholinergic interneurons 
become silenced and ACh release is inhibited (via inhibition of 
Ca
v
2-type Ca2+ conductances and/or Kv
+ channel opening; Raiteri 
et al., 1984; Schoffelmeer et al., 1986; Yan and Surmeier, 1996; 
Calabresi et al., 1998, 2000; Zhang et al., 2002a; Zhou et al., 2003; 
Ding et al., 2006; Bonsi et al., 2008). The reduction in ACh release 
following mAChR autoreceptor activation consequently deacti-
vates nAChRs on dopaminergic axons, and in turn, increases the 
sensitivity of DA release to presynaptic depolarization frequency 
as seen following inhibition/desensitization of nicotinic receptors 
(see Figure 1).
These data revise our understanding of striatal mAChR–DA 
interactions in several ways. Firstly, striatal mAChRs offer variable, 
bidirectional control of DA release probability depending on presy-
naptic activity. This reconciles previous contradictory findings since 
striatal mAChRs do not simply suppress or enhance DA release 
but can do both depending on the frequency of depolarization. 
Secondly, this variable mAChR control of DA release is not via 
multiple striatal neuron types but via the control of ACh release 
from striatal cholinergic interneurons. These mAChRs, by modi-
fying ACh release, powerfully gate the nAChR regulation of DA 
release. Finally, we also show important differences in the mAChR 
subtypes regulating DA (and cholinergic interneurons) in senso-
rimotor- versus limbic-associated striatum.
machr subtypes anD locations within striatum
Five different types of mAChRs exist in the striatum, M
1
–M
5
, these 
G-protein-coupled mAChRs are present throughout the striatum 
on a variety of neurons and axon terminals. Like DA receptors, these 
mAChRs are commonly divided into two families, M
1
-like (M
1
, M
3
, 
and M
5
) and M
2
-like (M
2
 and M
4
) according to the G-protein the 
receptor is coupled to. M
1
-like receptors are coupled to the G
s
 class 
of G
α
 proteins, whereas M
2
-like receptors are coupled to G
i
 proteins, 
thereby modulating different intracellular signaling pathways. The 
muscarinic receptor subtypes M
1
, M
2
, and M
4
, are the dominant 
striatal subtypes (Zhang et al., 2002b; Zhou et al., 2003). There 
is now considerable evidence that discrete expression and func-
tion of M
1
, M
2
, and M
4
 receptors can be partitioned to different 
striatal neurons and neurotransmitter interactions. For example, 
MSNs express primarily M
1
 and M
4
, with M
4
 receptors dominant on 
striatonigral MSNs with very low or undetectable levels of M
2
, M
3
, 
and M
5
 (Weiner et al., 1990; Levey et al., 1991; Santiago and Potter, 
2001; Yan et al., 2001; Shen et al., 2005; Wang et al., 2006). Striatal 
cholinergic interneurons by contrast have dominant expression and 
function of M
2
 and M
4
 mAChRs (Yan and Surmeier, 1996; Bernard 
et al., 1998; Alcantara et al., 2001; Ding et al., 2006). M
5
 receptors are 
expressed by midbrain DA neurons where they mediate midbrain 
actions of ACh inputs (Forster et al., 2002; Lester et al., 2010), but 
current anatomical evidence does not suggest that they are trans-
ported to DA axon terminals in the striatum (Weiner et al., 1990).
DiFFerent machr subtypes are responsible For regulation oF 
striatal Dopamine in Dorsal versus ventral striatum
The mAChRs regulating striatal DA release differ between dorsal 
and ventral striatal subterritories. Due to the poor pharmacological 
selectivity of drug ligands for specific distinct muscarinic receptor 
 suggested might indicate a role for α6α4β2* nAChRs in regula-
tion of DA release in the central CPu region (Drenan et al., 2010). 
However, this role remains to be established for native α6 subu-
nits in CPu, and moreover, unpublished data from our own lab in 
knockout mice continues to suggest that α6β2*-nAChRs in dorsal 
striatum play only a limited role compared to α4β2*-nAChRs, 
whereas α4α6β2*-nAChRs may dominate β2*-nAChR function 
in NAc (Exley et al., 2011).
Frequency-DepenDent regulation oF Dopamine 
release probability by muscarinic autoreceptors 
(machrs) on cholinergic interneurons
Like nAChRs, muscarinic receptors (mAChRs) are also able to 
regulate striatal DA availability. Until recently, data within the lit-
erature was conflicting, with some reports suggesting that mAChRs 
enhance DA release (Lehmann and Langer, 1982; Raiteri et al., 
1984; Schoffelmeer et al., 1986; Xu et al., 1989; De Klippel et al., 
1993; Zhang et al., 2002b; Grilli et al., 2008), and others report-
ing the opposite (Schoffelmeer et al., 1986; Kemel et al., 1989; Xu 
et al., 1989; De Klippel et al., 1993; Kudernatsch and Sutor, 1994; 
Zhang et al., 2002b; Tzavara et al., 2004). Recent data from our lab 
has revealed that mAChRs can in fact regulate DA bidirectionally 
depending on activity of DA neurons (Threlfell et al., 2010). This 
activity-dependent regulation of DA by mAChRs is reminiscent of 
that shown by nicotinic receptors (Rice and Cragg, 2004; Zhang 
and Sulzer, 2004; Exley et al., 2008).
Activation of striatal mAChRs inhibits DA release by single 
pulses or low frequencies of presynaptic activity, but enhances the 
sensitivity of DA release to frequency, increasing DA released by 
higher frequencies (Threlfell et al., 2010). Thus, either activation 
of mAChRs, or inhibition/desensitization of nAChRs enhances the 
sensitivity of DA release to frequency, and as such restores release 
to exhibit classical, dynamic probability of neurotransmitter release 
as seen at other synapses (Thomson, 2000a,b). However, unlike for 
striatal nAChRs, there is no anatomical evidence for the presence 
of striatal mAChRs on dopaminergic axon terminals to influence 
DA release directly (Jones et al., 2001; Zhang et al., 2002b; Zhou 
et al., 2003). Many other striatal neurons by contrast, express and 
are regulated by mAChRs, including striatal cholinergic interneu-
rons (Bernard et al., 1992, 1998; Yan and Surmeier, 1996; Alcantara 
et al., 2001; Bonsi et al., 2008), GABAergic interneurons (Koos 
and Tepper, 2002), MSNs (Weiner et al., 1990; Levey et al., 1991; 
Calabresi et al., 2000; Yan et al., 2001), and glutamatergic afferents 
(Sugita et al., 1991; Calabresi et al., 2000; Pakhotin and Bracci, 
2007). Previous studies have identified regulation of DA release 
by mAChRs on a variety of striatal neurons/inputs. For example, 
mAChR regulation of GABA acting at GABA
A
 receptors has been 
implicated in the control of DA in protocols using high [K+] to 
evoke [3H] DA release (Zhang et al., 2002b), but the mAChR modu-
lation of dynamic DA release probability that we have described 
during discrete electrical stimuli persists in the presence of synaptic 
blockers for GABA/glutamate (Threlfell et al., 2010). Rather, this 
dynamic regulation of striatal DA by mAChRs requires cholinergic 
tone at nAChRs on DA axons, since blockade of ACh input from 
cholinergic interneurons to nAChRs precludes effects of mAChR 
activation and vice versa. Striatal cholinergic interneurons express 
somatodendritic and axonal mAChRs (Bernard et al., 1992, 1998; 
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 differing mAChR control of DA release in dorsal striatum and NAc. 
These regional differences in M
2
/M
4
 function could ultimately be 
exploited for discrete modulation of DA/ACh. For example, ACh/
DA function might be modified selectively in NAc by activation 
of M
4
Rs, and in dorsal striatum by M
2
R inhibition. It is possible 
that regional differences may exist due to differential intracellular 
coupling of M
2
- and M
4
-mAChRs on cholinergic interneurons 
in different striatal regions, or perhaps differential expression of 
M
2
- and M
4
-mAChRs on cholinergic interneurons in these two 
regions. Further electrophysiological characterization of cholin-
ergic interneurons in mice lacking M
2
- or M
4
-mAChRs may shed 
light on potential differences between dorsal and ventral striatum, 
and is currently underway.
summary anD perspective
Striatal nAChRs and mAChRs powerfully modulate DA trans-
mission in a manner that varies with presynaptic activity in DA 
neurons. This regulation can strongly influence how DA synapses 
transmit discrete bursts in neuronal activity that signal events of 
motivational salience, and in turn will influence all DA-dependent 
functions of the striatum. Intriguingly, cholinergic modulation of 
DA transmission within striatum is via regionally specific portfolios 
of nicotinic (Exley et al., 2008, 2011) and muscarinic (Threlfell 
et al., 2010) receptors (Figure 2), which may ultimately enable 
region-specific targeting of striatal function. For example, ACh/
DA function within striatum could be modified selectively in NAc 
by activation of M
4
Rs, and in dorsal striatum by M
2
R inhibition. 
A specific nAChR such as the α4α6β2*-nAChR in NAc might be 
a target to exploit in the treatment of nicotine addiction. There are 
longstanding notions that there is a postsynaptic antagonistic bal-
ance between striatal ACh and DA and that antimuscarinic thera-
pies are useful in diseases like Parkinson’s and dystonia (e.g., see 
Pisani et al., 2007). The suppression of striatal ACh release by M
2
/M
4
 
autoreceptors together with the effects of M
2
/M
4
 receptor activation 
on DA transmission reviewed here give support to the notion that 
enhancers of muscarinic M
2
/M
4
 receptor function might be a use-
ful therapy in such disorders (Pisani et al., 2007). More generally, 
these data also highlight that regulation of DA neurotransmission 
by a given neuromodulator is not fixed, or unidirectional; it can 
be variable and bidirectional in an activity-dependent manner, a 
principle which may apply equally to other neuromodulators and 
neurotransmitters.
With increasing availability of new molecular biological tools 
facilitating neuron-specific elimination/expression of proteins, 
we are in a better position than ever to advance our appreciation 
of how receptors in the basal ganglia are able to regulate striatal 
function. The advancing field of optogenetics which exploits genet-
ics to incorporate light activated ion channels (rhodopsins) into 
genetically defined populations of neurons to allow activation or 
inhibition of these neurons with high temporal precision, will 
undoubtedly facilitate future studies of the complex interplay of a 
multitude of neurotransmitters and neuromodulators within the 
highly heterogenous striatum. When considering how striatal out-
put governs different behaviors, it is imperative to assess the role 
played by interactions between many striatal neurotransmitters 
and neuromodulators and the ACh–DA interaction is one powerful 
interaction that should be given appropriate consideration.
subtypes (ligands are subtype-preferring but not selective), we have 
made use of transgenic mice lacking individual mAChR subtypes 
(Wess et al., 2003) to study the receptor subtypes that are respon-
sible for regulation of DA in specific striatal subregions. The use 
of knockout mice as tools to study normal receptor function is not 
always free from caveats as such mice can often display significant 
compensation for gene deletions. However, there appears to be 
little or no compensation in remaining mAChRs for the subtype-
specific null mice used here (Gomeza et al., 1999a,b). Given that 
cholinergic interneurons are responsible for a powerful modulation 
of striatal DA, we studied mice lacking the receptors those interneu-
rons usually express as autoreceptors: M
2
- and M
4
-mAChRs. We 
also explored mAChR control of DA release in M
5
-mAChR null 
mice. Although there is a lack of anatomical evidence that these 
receptors can be found on striatal DA axons, midbrain DA neurons 
express M
5
 receptors for midbrain ACh function (Forster et al., 
2002; Lester et al. 2010) and there is some limited evidence that 
striatal M
5
Rs might regulate DA transmission (Zhang et al., 2002b; 
Bendor et al., 2010).
In dorsal striatum, a region classically associated with motor 
function, both M
2
- and M
4
-mAChRs are necessary for muscarinic 
regulation of DA release. Deletion of either M
2
- or M
4
-mAChRs 
prevents muscarinic receptor modulation of DA (Threlfell et al., 
2010). By contrast in more limbic striatal regions, in the NAc core 
or shell, only the M
4
-mAChR is necessary for muscarinic receptor 
control (Threlfell et al., 2010). Deletion of M
2
-mAChRs in the 
NAc core or shell does not prevent muscarinic control of DA; only 
deletion of the M
4
-mAChR eliminates muscarinic control. In both 
dorsal striatum and NAc, elimination of the M
5
-mAChR has no 
effect on the activity-dependent regulation of DA by muscarinic 
receptors therefore they do not participate in activity-dependent 
regulation of DA by mAChR agonists. However, muscarinic-medi-
ated suppression of DA release following single pulse stimulation 
in mice lacking the M
5
R does appear to be more pronounced in 
both dorsal and ventral striatum suggesting that if presynap-
tic M
5
Rs do exist on a subset of DA terminals, they function to 
enhance DA release, as suggested by others (Zhang et al., 2002b; 
Bendor et al., 2010).
At present, it is unclear why such differences in mAChR control 
of DA release by M
2
/M
4
 mAChRs would exist between dorsal and 
ventral striatum. It is currently unknown whether these differ-
ences are attributable to different expression/role of M
4
Rs versus 
M
2
Rs in cholinergic interneurons that innervate each territory, 
or a different basal ACh tone at nAChRs, or whether there are 
other intrinsic regional differences in cholinergic interneurons 
including compensatory adaptations that can accommodate loss 
of M
2
Rs in NAc but not in dorsal striatum. There is no com-
parative study of expression/function of mAChRs in regulation of 
cholinergic activity in dorsal versus ventral striatum and no evi-
dence for a difference in the levels of ACh reaching nAChRs (Exley 
et al., 2008). There are however, reports that mAChRs are found 
at higher levels in ventral than dorsal striatum in rats (Tayebati 
et al., 2004) and that cholinergic interneurons in limbic/prefrontal 
versus sensorimotor territories can be differentiated by different 
expression levels of other types of receptors (μ-opioid; Jabourian 
et al., 2005). Thus, distinct muscarinic mechanisms/receptors 
in subpopulations of cholinergic interneurons may explain the 
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